| 國立政治大學 |
2018 |
Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance
|
Chuang, Yu-Chung;Lin, Hsin-Yi;Chen, Pao-Yu;Lin, Chi-Ying;Chen, Yee-Chun;Wang, Jann-Tay;Chang, Shan-Chwen; 林馨怡; Lin, Hsin-Yi |
| 臺大學術典藏 |
2020-12-29T03:08:54Z |
Survival of patients with vancomycin-resistant enterococcus faecium bacteremia treated with conventional or high doses of daptomycin or linezolid is associated with the rate of bacterial clearance
|
Chuang Y.-C.;Lin H.-Y.;Chen P.-Y.;Lin C.-Y.;Chen Y.-C.;Jann-Tay Wang;Chang S.-C.; Chuang Y.-C.; Lin H.-Y.; Chen P.-Y.; Lin C.-Y.; Chen Y.-C.; JANN-TAY WANG; Chang S.-C. |
| 臺大學術典藏 |
2018 |
Survival of patients with vancomycin-resistant enterococcus faecium bacteremia treated with conventional or high doses of daptomycin or linezolid is associated with the rate of bacterial clearance
|
Yu-Chung Chuang;Lin H.-Y.;Chen P.-Y.;Lin C.-Y.;Chen Y.-C.;Wang J.-T.;Chang S.-C.; YU-CHUNG CHUANG; Lin H.-Y.; Chen P.-Y.; Lin C.-Y.; Chen Y.-C.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-03-13T04:23:44Z |
Survival of patients with vancomycin-resistant enterococcus faecium bacteremia treated with conventional or high doses of daptomycin or linezolid is associated with the rate of bacterial clearance
|
Chuang Y.-C.; Lin H.-Y.; PAO-YU CHEN; Lin C.-Y.; Chen Y.-C.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2018 |
Survival of patients with vancomycin-resistant enterococcus faecium bacteremia treated with conventional or high doses of daptomycin or linezolid is associated with the rate of bacterial clearance
|
SHAN-CHWEN CHANG; Wang J.-T.; Chen Y.-C.; Lin C.-Y.; Chen P.-Y.; Lin H.-Y.; Chuang Y.-C.; Chuang Y.-C.;Lin H.-Y.;Chen P.-Y.;Lin C.-Y.;Chen Y.-C.;Wang J.-T.;Shan-Chwen Chang |
| 國立臺灣大學 |
2013 |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
Cheng, Aristine; Sun, Hsin-Yun; Lee, Ching-Wen; Ko, Wen-Je; Tsai, Pi-Ru; Chuang, Yu-Chung; Hu, Fu-Chang; Chang, Shan-Chwen; Chen, Yee-Chun; 張上淳; 孫幸筠; 陳宜君; 柯文哲; 莊祐中; 蔡壁如 |
| 臺大學術典藏 |
2018-09-10T09:38:50Z |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
Cheng, Aristine;Sun, Hsin-Yun;Lee, Ching-Wen;Ko, Wen-Je;Tsai, Pi-Ru;Chuang, Yu-Chung;Hu, Fu-Chang;Chang, Shan-Chwen;Chen, Yee-Chun; Cheng, A. and Sun, H.-Y. and Lee, C.-W. and Ko, W.-J. and Tsai, P.-R. and Chuang, Y.-C. and Hu, F.-C. and Chang, S.-C. and Chen, Y.-C.; 張上淳 ;孫幸筠 ;陳宜君 ;柯文哲 ;莊祐中 ;蔡壁如; ARISTINE CHENG; Cheng, Aristine; SHAN-CHWEN CHANG; Sun, Hsin-Yun; YEE-CHUN CHEN; Lee, Ching-Wen; Ko, Wen-Je; HSIN-YUN SUN; YU-CHUNG CHUANG; Tsai, Pi-Ru; Chuang, Yu-Chung; Hu, Fu-Chang; Chang, Shan-Chwen; Chen, Yee-Chun |
| 臺大學術典藏 |
2020-09-29T01:47:48Z |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
YEE-CHUN CHEN; Cheng A.; Sun H.-Y.; Lee C.-W.; Ko W.-J.; Tsai P.-R.; Chuang Y.-C.; Hu F.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-12-29T03:48:00Z |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
Chen Y.-C.; Chang S.-C.; Hu F.-C.; YU-CHUNG CHUANG; Tsai P.-R.; Cheng A.; Sun H.-Y.; Lee C.-W.; Ko W.-J. |
| 臺大學術典藏 |
2020-12-29T05:33:27Z |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
Ko W.-J.; Tsai P.-R.; Lee C.-W.; HSIN-YUN SUN; Cheng A.; Chen Y.-C.; Chang S.-C.; Chuang Y.-C.; Hu F.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:17Z |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
Cheng A.; Sun H.-Y.; Lee C.-W.; Ko W.-J.; Tsai P.-R.; Chuang Y.-C.; Hu F.-C.; Chang S.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-08-16T08:36:25Z |
Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: A propensity-matched analysis
|
ARISTINE CHENG; Sun H.-Y.; Lee C.-W.; Ko W.-J.; Tsai P.-R.; Chuang Y.-C.; Hu F.-C.; Chang S.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2022-08-19T00:21:14Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
CHIUN HSU; Cheng A.-L.; Yang P.-C.; Yu C.-J.; Yang C.-H.; Kuo S.-H. |
| 國立臺灣大學 |
2005 |
Survival of Stage Iiib/Iv Non-Small Cell Lung Cancer Patients Who Received Chemotherapy but Did Not Participate in Clinical Trials
|
郭頌鑫; 楊志新; 余忠仁; 許駿; 鄭安理; 楊泮池; KUO, SUNG-HSIN; YANG, CHIH-HSIN; YU, CHONG-JEN; HSU, CHIUN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H;Chih-Hsin Yang;Yu C.-J;Hsu C;Cheng A.-L;Yang P.-C.; Kuo S.-H; CHIH-HSIN YANG; Yu C.-J; Hsu C; Cheng A.-L; Yang P.-C. |
| 臺大學術典藏 |
2020-04-10T12:51:28Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.;Yang C.-H.;Yu C.-J.;Chiun Hsu;Cheng A.-L.;Yang P.-C.; Kuo S.-H.; Yang C.-H.; Yu C.-J.; Chiun Hsu; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:54Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C.; Kuo S.-H.; Yang C.-H.; Kuo S.-H.;Yang C.-H.;Chong-Jen Yu;Hsu C.;Cheng A.-L.;Yang P.-C. |
| 臺大學術典藏 |
2021-02-23T08:26:43Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Sung-Hsin Kuo;Yang C.-H.;Yu C.-J.;Hsu C.;Cheng A.-L.;Yang P.-C.; SUNG-HSIN KUO; Yang C.-H.; Yu C.-J.; Hsu C.; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:18Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; ANN-LII CHENG; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:46Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.;Yang C.-H.;Yu C.-J.;Hsu C.;Cheng A.-L.;Pan-Chyr Yang; Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; Cheng A.-L.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:40Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.; Yang C.-H.; CHONG-JEN YU; Hsu C.; Cheng A.-L.; Yang P.-C. |
| 臺北醫學大學 |
1998 |
Survival of Taenia solium cysticerci in carcasses of pigs kept at 4 C.
|
鍾文政; Fan PC; Ma YX; Kuo CH ; Chung WC |
| 國立臺灣大學 |
2009 |
Survival of the acid-adapted Bacillus cereus in acidic environments
|
Chen, Jui-Lin; Chiang, Ming-Lun; Chou, Cheng-Chun |
| 國立臺灣大學 |
2009-01 |
Survival of the acid-adapted Bacillus cereus in acidic environments.
|
Chen, J. L.; Chiang, M. L.; Chou, C. C. |
| 國立臺灣大學 |
2013 |
Survival of Transferred Ileum after Ischemia Time Longer than 1 Hour: A Clinical Result Different from Animal Studies
|
Chen, Shih-Heng; Tang, Yueh-Bih; Chen, Hung-Chi; 湯月碧 |
| 中國醫藥大學 |
2013-08 |
Survival of Transferred Ileum after Ischemia Time Longer than 1 Hour: A Clinical Result Different from Animal Studies
|
(Shih-Heng Chen);(Yueh-Bih Tang);陳宏基(Hung-Chi Chen)* |
| 國立臺灣大學 |
2009 |
Survival of Vibrio parahaemolyticus under environmental stresses as influenced by growth phase and pre-adaptation treatment
|
Chiang, Ming-Lun; Chou, Cheng-Chun |
| 國立臺灣大學 |
2009-06 |
Survival of Vibrio parahaemolyticus under environmental stresses as influenced by growth phase and pre-adaptation treatment.
|
Chiang, M. L.; Chou, C. C. |
| 國立成功大學 |
1999-01 |
Survival of Vibrio vulnificus in whole blood from patients with chronic liver disease: association with phagocytosis by neutrophils and serum ferritin levels
|
Hor, L. I.; Chang, Ting-Tsung; Wang, S. T. |
| 亞洲大學 |
2018-07 |
Survival outcome and mortality rate in patients with migraine: a population-based cohort study.
|
Harnod, Tomor;Harnod, Tomor;Lin, Cheng-Li;Lin, Cheng-Li;高嘉鴻;Kao, Chia-Hung;* |
| 臺大學術典藏 |
2022-08-19T00:21:10Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang P.-C.; Chang G.-C.; CHIUN HSU; Gow C.-H.; Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P. |
| 國立臺灣大學 |
2006 |
Survival Outcome and Predictors of Gefitinib Antitumor Activity in East Asian Chemonaive Patients with Advanced Nonsmall Cell Lung Cancer
|
楊志新; 施金元; 陳焜結; 余忠仁; 楊宗穎; 林京珮; 蘇文彬; 高劍虹; 許駿; 張基晟; 楊泮池; YANG, CHIH-HSIN; SHIH, JIN-YUAN; CHEN, KUN-CHIEH; YU, CHONG-JEN; YANG, TSUNG-YING; LIN, CHING-PEI; SU, WEN-PIN; GOW, CHIEN-HUNG; HSU, CHIUN; CHANG, GEE-CHEN; YANG, PAN-CHYR |
| 臺大學術典藏 |
2018-09-10T05:44:42Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang, C.-H. and Shih, J.-Y. and Chen, K.-C. and Yu, C.-J. and Yang, T.-Y. and Lin, C.-P. and Su, W.-P. and Gow, C.-H. and Hsu, C. and Chang, G.-C. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-26T09:27:26Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Chih-Hsin Yang;Shih J.-Y;Chen K.-C;Yu C.-J;Yang T.-Y;Lin C.-P;Su W.-P;Gow C.-H;Hsu C;Chang G.-C;Yang P.-C.; CHIH-HSIN YANG; Shih J.-Y; Chen K.-C; Yu C.-J; Yang T.-Y; Lin C.-P; Su W.-P; Gow C.-H; Hsu C; Chang G.-C; Yang P.-C. |
| 臺大學術典藏 |
2006 |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; CHONG-JEN YU; Chen K.-C.; Yang C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:34:05Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Yang T.-Y.; Yang C.-H.; JIN-YUAN SHIH; Chen K.-C. |
| 臺大學術典藏 |
2020-04-10T12:51:25Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Gow C.-H.; Chiun Hsu; Chang G.-C.; Yang P.-C.; Su W.-P.; Lin C.-P.; Yang T.-Y.; Yu C.-J.; Chen K.-C.; Shih J.-Y.; Yang C.-H.; Yang C.-H.;Shih J.-Y.;Chen K.-C.;Yu C.-J.;Yang T.-Y.;Lin C.-P.;Su W.-P.;Gow C.-H.;Chiun Hsu;Chang G.-C.;Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:49Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Pan-Chyr Yang; Yang C.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2022-06-27T07:06:33Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang C.-H.; Shih J.-Y.; Chen K.-C.; CHONG-JEN YU; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C. |
| 中國醫藥大學 |
2007-11 |
Survival outcome by early chemoradiation therapy salvage or early surgical salvage for the treatment of hypopharyngeal cancer
|
鄒永恩(Yung-An Tsou); 林孟宏; 花俊宏(Chun-Hung Hua); 曾憲彰(Hsien-Chang Tseng); 陳尚文(Shang-Wen Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai) |
| 國家衛生研究院 |
2005 |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Yeh, KH; Yu, YC; Whang-Peng, J; Yang, PC |
| 國立臺灣大學 |
2005 |
Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment
|
楊志新; 陳明君; 鄭安理; 徐志宏; 葉坤輝; 汪彭嘉康; 楊泮池; YANG, CHIH-HSIN; CHEN, MIN-CHUN; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; JACQUELINE, WHANG-PENG; YANG, PAN-CHYR |
| 臺大學術典藏 |
2020-04-28T07:25:36Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.; Chen M.-C.; Cheng A.-L.; CHIH-HUNG HSU; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.; Yang C.-H.;Chen M.-C.;Cheng A.-L.;Chih-Hung Hsu;Yeh K.-H.;Yu Y.-C.;Whang-Peng J.;Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Chih-Hsin Yang;Chen M.-C;Cheng A.-L;Hsu C.-H;Yeh K.-H;Yu Y.-C;Whang-Peng J;Yang P.-C.; CHIH-HSIN YANG; Chen M.-C; Cheng A.-L; Hsu C.-H; Yeh K.-H; Yu Y.-C; Whang-Peng J; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:41Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
PAN-CHYR YANG; Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Yeh K.-H.;Yu Y.-C.;Whang-Peng J.;Pan-Chyr Yang; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:15Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:48Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Yu Y.-C.;Whang-Peng J.;Yang P.-C.; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Yu Y.-C.; Whang-Peng J.; Yang P.-C. |
| 國立臺灣大學 |
2005-07 |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment.
|
Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Kun-Huei, Yeh; Yu, YC; Whang-Peng, J; Yang, PC. |
| 中國醫藥大學 |
2015-08 |
Survival outcome of patients with nasopharyngeal carcinoma: a nationwide analysis of 13 407 patients in Taiwan.
|
(Huang, W.-Y.);林橙莉;(Lin, C.-Y.);(Jen, Y.-M.);(Lo, C.-H.);宋鴻樟(Fung-Chang Sung);高嘉鴻(Chia-Hung Kao)* |
| 國立成功大學 |
2022-03-8 |
Survival Outcome of Surgical Resection vs. Radiotherapy in Brain Metastasis From Colorectal Cancer: A Meta-Analysis
|
Chang;Yu;Wong;Chia-En;Lee;Po-Hsuan;Huang;Chi-Chen;Lee;Jung-Shun |
